Skip to main content

Regulatory issues and generic names

  • Chapter
Brand Medicine
  • 121 Accesses

Abstract

At a time when thousands of trade mark applications and registrations1 for pharmaceuticals populate the world’s trade mark registers, it is becoming increasingly difficult to create, clear and protect pharmaceutical marks on a global basis. Here we will explore the regulatory issues and legal aspects which impact on the creation of pharmaceutical brands as well as the criteria for trade mark searching and protection for pharmaceutical brands. We will then turn our attention to ways of maintaining the brand well after registration and the use of trade mark notices and symbols. We will also touch upon domain names.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 2001 Alison Azulay

About this chapter

Cite this chapter

Azulay, A. (2001). Regulatory issues and generic names. In: Blackett, T., Robins, R. (eds) Brand Medicine. Palgrave Macmillan, London. https://doi.org/10.1057/9780230522510_14

Download citation

Publish with us

Policies and ethics